Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Photo of: Patrick Flochel
Member of the Supervisory Board

Patrick Flochel

Patrick Flochel has held many roles at local and global levels at EY (Ernst & Young Global Limited) in Paris, Brussels, London, Tokyo and Zurich. Prior to his retirement as a senior partner in 2021, he spent almost two decades working with pharmaceutical sector clients, leading the EY relationship with several of the world’s largest pharmaceutical companies.  

Patrick was a member of the EY Life Sciences sector global leadership team and participated in the development of EY’s point-of-view and strategic-level ideas about the evolution of the life sciences industry. He has frequently spoken at global events and contributed to industry articles in the trade and general press. 

A key area of interest for Patrick has been how pharmaceutical companies can contribute to making the health systems they are a part of efficient, sustainable, and equitable. He is concerned with how the private sector, government and agile entrepreneurs combine resources and expertise to develop the health ecosystems of the future. 

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved